Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 185.86

-0.1%

Feb 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (27006)	12/23/1998 8:47:00 PM
From: Machaon	Read Replies (2) of 32384

I was looking back to last years LGND annual report to see the projections for Targretin and Panretin. It looks like their projections were on target. Here's what I found: Annual Report: Panretin Gel for KS, late 1998 or early 1999. - "If" approved shortly, they will be right on target. Annual Report: Targretin Gel and Targretin Capsules NDA for CTCL, 2nd half 1998 or early 1999. - They haven't missed this deadline yet. Also, they started the Phase II Targretin trials for breast cancer in November 1998. I think that this was a little later than expected. The $130 million Elan deal, of course, was not in the Annual. Doesn't sound like they have missed their projections, yet. We can't shoot Robinson for being close to projections. Henry, what do you know about the NDAs for Targretin? Are we going to see both of them, capsules and gel, in the 1st half of 1999 (best guess)?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next